Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -241.99M | -244.17M | -234.41M | -252.18M | -208.67M |
| Total Depreciation and Amortization | 11.49M | 12.75M | 13.50M | 14.37M | 15.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.71M | 97.70M | 71.82M | 67.38M | -8.33M |
| Change in Net Operating Assets | -5.76M | -10.11M | -9.26M | -10.30M | -4.58M |
| Cash from Operations | -132.55M | -143.83M | -158.35M | -180.74M | -206.18M |
| Capital Expenditure | -1.09M | -938.00K | -501.00K | -4.55M | -17.72M |
| Sale of Property, Plant, and Equipment | 1.43M | 1.43M | 771.00K | 635.00K | 253.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.74M | -40.73M | 23.08M | 117.06M | 128.75M |
| Cash from Investing | -7.40M | -40.24M | 23.35M | 113.15M | 111.28M |
| Total Debt Issued | -- | -- | -56.00K | 116.00K | 7.74M |
| Total Debt Repaid | -353.00K | -347.00K | -258.00K | -171.00K | -85.00K |
| Issuance of Common Stock | 128.01M | 129.08M | 112.04M | 4.32M | 6.74M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -36.00K | 0.00 | 0.00 | 0.00 | -60.00K |
| Cash from Financing | 127.62M | 128.73M | 111.73M | 4.27M | 14.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.33M | -55.33M | -23.28M | -63.32M | -80.56M |